Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases. Long MD, Weaver KN, Zhang X, Chun K, et al. Clin Gastroenterol Hepatol 2022;20:1881-1883.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Long MD, Weaver KN, Zhang X, Chun K, et al. Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2022;20:1881-1883.
PMID: 35150924